Table 3.
Univariate | Multivariate* | |||
---|---|---|---|---|
OR (95%CI) |
P-value | Adjusted OR (95%CI) |
P-value | |
Female | 0.31 (0.19–0.49) | <0.001 | 0.34 (0.16–0.68) | 0.003 |
Age ≤ 70 yrs | Ref | Ref | Ref | Ref |
Age > 70 yrs | 3.57 (2.3–5.58) | <0.001 | 1.8 (0.91–3.59) | 0.093 |
Comorbidities | ||||
CKD stage 4–5 | 3.72 (2.35–5.87) | <0.001 | 3.21 (1.45–7.27) | 0.004 |
Metabolic disease | 2.29 (1.39–3.7) | <0.001 | 1.35 (0.67–2.64) | 0.395 |
Heart conditions | 3.23 (2.09–5.03) | <0.001 | 1.53 (0.73–3.2) | 0.256 |
Neurodegenerative disease | 3.37 (1.5–7.04) | 0.002 | 1.79 (0.43–6.82) | 0.403 |
Cerebral vascular disease | 3.87 (2.09–6.95) | <0.001 | 0.96 (0.35–2.64) | 0.943 |
Lung disease | 2.61 (1.33–4.83) | 0.003 | 2.46 (0.91–6.38) | 0.067 |
Acute conditions | 3.35 (1.55–6.79) | 0.001 | 1.91 (0.67–5.16) | 0.210 |
Cancer | 4.82 (2.93–7.84) | <0.001 | 9.52 (4.19–22.61) | <0.00 |
Isolated hypertension | 1.18 (0.66–2.03) | 0.557 | – | – |
Bone fracture | 2.48 (0.56–7.94) | 0.164 | – | – |
Autoimmune diseases | NA | NA | – | – |
Long-term bedridden | 7.51 (4.76–11.91) | <0.001 | 4.94 (2.36–10.44) | <0.001 |
COVID-19 vaccination | ||||
Not fully vaccinated | Ref | Ref | Ref | Ref |
Fully vaccinated or booster | 0.11 (0.04–0.25) | <0.001 | 0.35 (0.12–0.87) | 0.034 |
*607 participants were enrolled for multivariate regression after removing missing values.
Note: Factors with adjusted OR <1.00 and P-value < 0.05 were considered as protective factors against illness progression while factors with adjusted OR >1.00 and P-value < 0.05 were considered as risk factors. Smaller or bigger adjusted HR indicates stronger protection or risk, respectively.
Abbreviation: OR: Odds Ratio; 95%CI: 95% confidence interval; CKD: Chronic Kidney Disease; yrs: years old;